Inhibrx, Inc. (INBX) Tops Q1 EPS by 8c

Inhibrx, Inc. (NASDAQ: INBX) reported Q1 EPS of ($2.15), $0.08 better than the analyst estimate of ($2.23).

For earnings history and earnings-related data on Inhibrx, Inc. (INBX) click here.

You May Also Be Interested In

• Citigroup set to join top banks in Anthropic IPO - Bloomberg
• Etsy upgraded to buy at BofA on durable growth, buyback potential
• Jefferies Downgrades Pop Mart International Group Ltd (9992:HK) to Hold